CAVA Group is recommended at Piper Sandler after recent stumble
Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at Neutral. Analyst Brian Mullan and his team see CAVA (NYSE:CAVA) as one of ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Iovance Biotherapeutics (IOVA), Xencor (XNCR) and Merus (MRUS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA – Research ...
Hosted on MSN14h
Piper Sandler Downgrades Arhaus (ARHS)
Fintel reports that on February 27, 2025, Piper Sandler downgraded their outlook for Arhaus (NasdaqGS:ARHS) from Overweight ...